drugset / Trial / NCT02441114
Pharmacokinetics of Co-administration of Seretide 250 Diskus (HCP0910) and Spiriva Capsule for Inhalation (HGP1011)
NaSingle-groupOpen-labelScreening
Summary
This pilot study was designed to evaluate the pharmacokinetic characteristics of fluticasone, salmeterol, and tiotropium after co-administration of HCP 0910 (Seretide 250 diskus) and HGP1011 (Spiriva capsule for inhalation) which are prescribed concomitantly for the patients with chronic obstructive pulmonary disease (COPD).
Timeline
- Start
- 2015-07
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone | Other / unclassified | 250 ug | Inhaled |
| Subject | Salmeterol | Other / unclassified | 72.5 ug | Inhaled |
| Subject | Tiotropium | Other / unclassified | 22.5 ug | Inhaled |